STAT

A new way to ease the organ shortage: ‘Regifting’ kidneys used in previous transplants

Since last year, a UCLA surgeon has transplanted three “regifted” kidneys from previous transplant recipients who died — breaking an unspoken taboo against using kidneys for a third time.

LOS ANGELES — Like many transplant surgeons, Dr. Jeffrey Veale got frustrated seeing so many of his patients die while waiting for a donor kidney. So he decided to do something about it: recycle.

Since last year, the UCLA surgeon has transplanted three “regifted” kidneys from previous transplant recipients who died with their donated kidneys still healthy — breaking an unspoken taboo against using kidneys for a third time. Veale said some 25 percent of people who receive kidney transplants die with organs that are perfectly acceptable for transplant into another recipient, and he is pushing hard for other transplant centers around the nation to do the same to help ease the crushing shortage of donor kidneys.

Such transplants have been done before, but infrequently. Veale is the first surgeon focused on making the re-use of transplanted kidneys routine.

“This breaks all policies and

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
Opinion: Virtual And Augmented Reality Can Save Lives By Improving Surgeons’ Training
Rapid advances in the development of medical devices in the 21st century are contributing to healthier lives, but bring with them a new challenge: teaching clinicians how to use these often-complicated technologies. Teaching them poorly, or failing t
STAT2 min read
This Troubled Biotech Needed Cash, So It Turned To A Predatory Lender: Its Own CEO
I don’t write about Northwest Biotherapeutics much anymore because it’s not cool to punch down. However, there was a juicy nugget in the cancer biotech’s recently filed 10-Q that had to be shared. It’s another example of a biotech executive getting r
STAT7 min read
Opinion: Novartis Violated FDA’s Sacred Principle: In God We Trust, All Others Must Bring Data
My experience in more than 40 years of developing and evaluating medical products, and two years working at the FDA, has convinced me that it's essential to have a second…